Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionValeo Financial Advisors, LLC
Latest Disclosed Ownership3,658 shares
Latest Disclosed Value $ 292,933
Valeo Financial Advisors, LLC reports 47.89% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 8, 2026 - Valeo Financial Advisors, LLC filed a 13F-HR form disclosing ownership of 3,658 shares of Edwards Lifesciences Corporation (MX:EW) valued at $292,933 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 7,020 shares of Edwards Lifesciences Corporation. This represents a change in shares of -47.89% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 3,658 -3,362 -47.89 293 -51.17 0.0070
2026-02-04 2025-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 7,020 -1,027 -12.76 598 -4.32 0.0133
2025-11-03 2025-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 8,047 2,172 36.97 626 36.17 0.0143
2025-09-12 2025-06-30 13F/A-1 EDWARDS LIFESCIENCES CORP COM Stock 28176E108 5,875 739 14.39 459 23.39 0.0113
2025-07-22 2025-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 5,813 677 455 0.0109
2025-04-30 2025-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 5,136 142 2.84 372 0.81 0.0104
2025-01-30 2024-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,994 508 11.32 370 24.66 0.0103
2024-10-10 2024-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,486 -647 -12.60 296 -37.55 0.0084
2024-07-10 2024-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 5,133 354 7.41 474 12.06 0.0148
2024-04-25 2024-03-31 13F/A-1 EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,779 -332 -6.50 423 8.74 0.0152
2024-04-19 2024-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,763 -348 455 0.0157
2024-01-29 2023-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 5,111 1,978 63.13 390 79.26 0.0157
2023-10-20 2023-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 3,133 -1,818 -36.72 217 -53.53 0.0099
2023-07-14 2023-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,951 562 12.80 467 28.65 0.0213
2023-04-17 2023-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 4,389 1,565 55.42 363 72.86 0.0175
2023-02-09 2022-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 2,824 2,824 211 0.0116
2021-07-22 2021-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 0 -969 -100.00 0 -100.00
2021-04-12 2021-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 969 0 0.00 81 -7.95 0.0037
2021-02-11 2020-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 969 -45 -4.44 88 8.64 0.0045
2020-10-28 2020-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,014 -558 -35.50 81 -25.69 0.0071
2020-07-20 2020-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 1,572 1,044 197.73 109 -3.54 0.0099
2020-04-13 2020-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 528 57 12.10 113 2.73 0.0120
2020-01-24 2019-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 471 70 17.46 110 25.00 0.0107
2019-10-15 2019-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 401 -5 -1.23 88 17.33 0.0097
2019-07-10 2019-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 406 -63 -13.43 75 -16.67 0.0086
2019-04-12 2019-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 469 16 3.53 90 30.43 0.0109
2019-01-30 2018-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 453 8 1.80 69 6.15 0.0097
2018-11-01 2018-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 445 18 4.22 65 10.17 0.0088
2018-08-14 2018-06-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 427 -41 -8.76 59 -9.23 0.0083
2018-04-12 2018-03-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 468 0 0.00 65 22.64 0.0104
2018-02-09 2017-12-31 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 468 221 89.47 53 96.30 0.0087
2017-11-15 2017-09-30 13F/A-1 EDWARDS LIFESCIENCES CORP COM Stock 28176E108 247 247 27 0.0061
2017-11-14 2017-09-30 13F EDWARDS LIFESCIENCES CORP COM Stock 28176E108 247 27
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.